Large mergers and acquisitions in the Indian pharmaceutical market are unlikely soon due to various uncertainties, says GV ...

In addition to a continued focus on growing drug pipelines, and the increasing use of artificial intelligence (AI) and data ...

With proper data governance, the pharma industry can improve patient-centricity in trials and bring lifesaving therapies to ...

Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

Mallinckrodt and Endo are merging in a cash and stock deal worth some $6.7 billion, the companies said Thursday. Under the ...

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, ...

In the week when U.S. President Donald Trump sounded alarm bells about Ireland “stealing the U.S. pharmaceutical industry” ...

4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion Araris will ...

Robert F. Kennedy Jr.’s health policies are stirring debate—here’s what they mean for you and the future of healthcare.

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...

The Future of Pharmaceutical Distribution Global Pharma Distributor is set to introduce new benchmarks for the industry. The company’s planned expansion into the Americas, including the ...